Drug regulators representing 28 countries in the European Union announced today that they are reviewing the safety of testosterone drugs because of recent studies demonstrating they seriously increase the risks of cardiovascular events such as heart attacks and strokes in older men.
The move by the European Medicines Agency comes three months after its counterpart in the U.S., the Food and Drug Administration, announced it was reviewing testosterone-containing drugs based on those same studies.
Those studies found the risks of heart attacks, strokes and even death doubled, and sometimes tripled, in older men who were on testosterone drugs such as AndroGel and Testim.
The leading testosterone lawyers at Ross Feller Casey have already filed six testosterone lawsuits involving men from across the country who suffered severe cardiovascular problems while taking testosterone-containing drugs. The firm is currently evaluating many other such claims and expects to file additional lawsuits soon.
If you or a loved one was injured by so-called Low T drugs, you should contact one of our testosterone attorneys immediately for a free consultation.
Disclaimer: Ross Feller Casey, LLP provides legal advice only after an attorney-client relationship is formed. Our website is an introduction to the firm and does not create a relationship between our attorneys and clients. An attorney-client relationship is formed only after a written agreement is signed by the client and the firm. Because every case is unique, the description of awards and summary of cases successfully handled are not intended to imply or guarantee that same success in other cases. Ross Feller Casey, LLP represents catastrophically injured persons and their families in injury and wrongful death cases, providing legal representation in Pennsylvania and New Jersey.